Scholarly Works

The FDA-mandated trial of safety of long-acting...

Journal article

The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?

Authors

Sears MR

Journal

Thorax, Vol. 68, No. 2,

Publisher

BMJ

Publication Date

January 1, 2013

DOI

10.1136/thoraxjnl-2012-202414

ISSN

0040-6376

Associated Experts

Malcolm Sears

Professor Emeritus, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology 3202 Clinical sciences

Medical Subject Headings (MeSH)

Adrenergic beta-Agonists Albuterol Asthma Clinical Trials as Topic Delayed-Action Preparations Disease Progression Drug Therapy, Combination Ethanolamines Formoterol Fumarate Glucocorticoids Humans Product Surveillance, Postmarketing Salmeterol Xinafoate United States United States Food and Drug Administration

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback